Active, not recruitingNCT04516499
Neurofilament Surveillance Project (NSP)
Studying Frontotemporal dementia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Bluefield Project to Cure Frontotemporal Dementia
- Principal Investigator
- Adam Boxer, MD, PhDUniversity of California, San Francisco
- Enrollment
- 342 enrolled
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2020 – 2027
Study locations (8)
- University of California, San Francisco, San Francisco, California, United States
- Mayo Clinic Florida, Jacksonville, Florida, United States
- Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
- Massachusetts General Hospital, Charlestown, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Washington University in St. Louis, St Louis, Missouri, United States
- Columbia University, New York, New York, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
Collaborators
Mayo Clinic · University of California, San Francisco
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04516499 on ClinicalTrials.govOther trials for Frontotemporal dementia
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07239843Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental DisordersFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- RECRUITINGNCT06856850Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical ApproachesFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- RECRUITINGNCT06803784Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative DisordersNeuromed IRCCS
- ENROLLING BY INVITATIONNCT07234851Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- ACTIVE NOT RECRUITINGNANCT06768996Music, Social Attention, and DementiaUniversity of California, San Francisco
- RECRUITINGNANCT06668610A Multifocal TDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early DementiaUniversity of Campania Luigi Vanvitelli
- RECRUITINGEARLY PHASE1NCT06511752Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive AphasiaUniversity of Texas at Austin
- RECRUITINGNCT06528964Proteinopathies Expression in Skin of Neurodegenerative DisordersUniversidad Autonoma de San Luis Potosí